Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.1 | 0.6 | 0.0 |
| Revenue growth | -100.0% | -88.2% | | |
| Cost of goods sold | 4.2 | 37.3 | 18.3 | -14.2 |
| Gross profit | -4.2 | -37.3 | -17.7 | 14.2 |
| Gross margin | | -56471.2% | -3176.8% | |
| Research and development | 47.6 | 71.4 | 20.6 | 10.7 |
| General and administrative | 28.4 | 51.8 | 12.2 | 3.0 |
| EBIT | -76.0 | -125.1 | -32.3 | -13.7 |
| EBIT margin | | -189507.6% | -5795.7% | |
| Pre-tax income | -75.2 | -137.2 | -40.0 | -14.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.1 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -75.2 | -137.2 | -40.0 | -14.2 |
| Net margin | | -207840.9% | -7173.6% | |
| |
| Diluted EPS | ($0.60) | ($1.79) | ($0.61) | ($0.42) |
| Shares outstanding (diluted) | 125.9 | 76.6 | 65.6 | 33.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|